GlobeNewswire

ONWARD Medical Delivers Revenue of EUR 2.5M in Q3 2026, with Sustained Commercial Momentum and Strong Clinical Execution
03/11/2026
EINDHOVEN, the Netherlands, Nov. 03, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and [...]
New research initiative will utilise AI to optimise Nordic energy grid capacity, improve resilience and prepare for future needs
03/11/2026
A new Nordic research initiative will develop artificial intelligence-based solutions to help power grid operators optimise the use of existing grid infrastructure, handle growing uncertainty and keep power grids [...]
Strong Cresemba® (isavuconazole) sales in Europe trigger USD 37.5 million milestone payment to Basilea
03/11/2026
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, November 03, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of [...]
Invitation to Idorsia's webcast and conference call to provide more context on the opportunity and launch approach for TRYVIO/JERAYGO
03/11/2026
Idorsia will host an investor webcast and conference call to provide more context on the opportunity and launch approach for TRYVIO™/JERAYGO™ (aprocitentan). Date: Wednesday, November 4, 2026 Time: 14:00 CET / 13:00 GMT [...]
argenx to Present at Upcoming Investor Conferences
03/11/2026
November 3, 2026 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), the immunology innovation company, today announced that members of the management team will participate in the following investor [...]
Philips delivers strong order intake growth, comparable sales growth and strong margin expansion in Q3; 2026 outlook reiterated
03/11/2026
November 3, 2026 Q3 2026 Group performance Comparable order intake increased by 8%, driven by strong Diagnosis & Treatment Group sales of EUR 4.4 billion, reflecting 3% comparable sales growth Income from operations [...]
Rhythm Pharmaceuticals and LG Chem Enter into Amendment to Bivamelagon Exclusive License Agreement
03/11/2026
-- Amendment revised royalty structure from low-to-mid-single digits to 1% on global net sales of Rhythm MC4R agonists, including setmelanotide, bivamelagon and RM-718 -- -- Rhythm to pay LG Chem additional fixed [...]
UPDATE -- Alamar Biosciences and Nightingale Health to Lead UK Biobank 80,000-Sample Neurodegenerative Disease Study
03/11/2026
Supported The Michael J Fox Foundation for Parkinson's Research, Alzheimer's Research UK and LifeArc, the study targets earlier detection, prevention and treatment of Parkinson’s disease, Alzheimer’s disease and other [...]
J-Star Holding Co., Ltd. Receives Shareholder Approval for Capital Restructuring and Reinforces Strategic Focus on U.S. Growth
02/11/2026
TAICHUNG, Taiwan and HOUSTON, Nov. 02, 2026 (GLOBE NEWSWIRE) -- J-Star Holding Co., Ltd. (Nasdaq: YMAT) (“J-Star” or the “Company”), an innovator in advanced composite manufacturing, today announced that shareholders [...]
Vireo Growth Inc. Receives Federal DEA Registrations for Florida Medical Cannabis Dispensaries
02/11/2026
MINNEAPOLIS, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOF) (“Vireo” or the “Company”), a leading cannabis company and agricultural markets platform, today announced that it has received [...]
Nuvectis Pharma to Report Third Quarter 2026 Financial Results on November 4, 2026
02/11/2026
Fort Lee, NJ, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative therapies for the [...]
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/11/2026
SAN DIEGO, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib [...]
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/11/2026
NEW YORK and WALTHAM, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the [...]
Opus Genetics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
02/11/2026
RESEARCH TRIANGLE PARK, N.C., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients [...]
MiNK Therapeutics to Report Third Quarter 2026 Results and Outline Progress in Randomized Clinical Development and Scalable iNKT Cell Therapy
02/11/2026
Webcast to highlight advancement of the randomized Phase 2 trial of agenT-797 in acute lung injury, the ARPA-H collaboration to advance deployable cell therapeutics, and new data released at the Society for [...]
Recursion Reports Third Quarter 2026 Financial Results and Extends Cash Runway; Highlights Positive Clinical Data in REC-4881 and REC-1245, Sanofi Development Candidate Option and Appointment of Fred Hassan as Chair
02/11/2026
New Phase 2 REC-4881 data presented at CGA-IGC in an expanded adult population aged 18 years and older show deep, durable polyp burden reductions in FAP, with activity throughout the GI tract and in larger, higher-risk [...]
DBV Technologies to Participate in Upcoming November Investor Conferences
02/11/2026
Châtillon, France, November 2, 2026 DBV Technologies to Participate in Upcoming November Investor Conferences DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT) (the “Company”), a late- [...]
DBV Technologies participera aux prochaines Conférences Investisseurs en novembre
02/11/2026
Châtillon, France, le 2 novembre (22 :30 CEST) 2026 DBV Technologies participera aux prochaines Conférences Investisseurs en novembre DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock Market : DBVT [...]
Olema Oncology to Participate in Upcoming Investor Conferences
02/11/2026
SAN FRANCISCO, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum